AMERICAN JOURNAL OF CARDIOLOGY

Scope & Guideline

Pioneering Research in Cardiology and Cardiovascular Medicine

Introduction

Welcome to your portal for understanding AMERICAN JOURNAL OF CARDIOLOGY, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0002-9149
PublisherEXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1958 to 2024
AbbreviationAM J CARDIOL / Am. J. Cardiol.
Frequency24 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807

Aims and Scopes

The American Journal of Cardiology focuses on advancing the field of cardiology through the publication of high-quality research and clinical studies. It aims to provide insights into the latest developments in cardiovascular disease management, prevention, and treatment methodologies.
  1. Cardiovascular Disease Management:
    Research related to the diagnosis, treatment, and management of various cardiovascular diseases, including coronary artery disease, heart failure, and arrhythmias.
  2. Transcatheter Procedures:
    Studies focusing on transcatheter interventions, such as transcatheter aortic valve replacement (TAVR) and catheter-based therapies for structural heart diseases.
  3. Risk Assessment and Prevention:
    Research on risk factors, prevention strategies, and management of cardiovascular disease, including lifestyle factors, pharmacological therapies, and screening methodologies.
  4. Technological Innovations:
    Investigation of new technologies and methodologies in cardiovascular imaging, surgical techniques, and device development, particularly in minimally invasive approaches.
  5. Patient Outcomes and Quality of Life:
    Studies assessing the outcomes of various treatments and interventions, including their impact on patients' quality of life and long-term health.
  6. Population Health and Disparities:
    Research addressing social determinants of health, health disparities, and the epidemiology of cardiovascular diseases across different populations.
The American Journal of Cardiology has seen an evolution in research themes, with certain areas emerging as prominent focuses of interest. These trends reflect the changing landscape of cardiovascular research and clinical practice, highlighting innovative approaches and current challenges in the field.
  1. Artificial Intelligence and Machine Learning:
    The integration of artificial intelligence (AI) and machine learning in cardiovascular research is on the rise, focusing on predictive analytics, risk stratification, and personalized medicine.
  2. Cardio-Oncology:
    Research at the intersection of cardiology and oncology is gaining momentum, focusing on the cardiovascular implications of cancer therapies and the management of patients with concurrent heart disease.
  3. Heart Failure with Preserved Ejection Fraction (HFpEF):
    Increased attention is being given to HFpEF, with studies exploring its pathophysiology, treatment strategies, and impact on patient outcomes, reflecting its growing prevalence.
  4. Telemedicine and Remote Monitoring:
    The COVID-19 pandemic has accelerated research into telemedicine and remote patient monitoring, particularly for managing chronic cardiovascular conditions and improving access to care.
  5. Patient-Centered Care:
    There is a growing emphasis on patient-reported outcomes and quality of life measures, with research increasingly focusing on how treatments affect patients' daily lives and overall well-being.

Declining or Waning

While the journal continues to publish a wide range of innovative research, certain themes have shown a decline in focus or frequency in recent years. These waning topics may reflect shifts in research priorities or advancements in understanding that have rendered previous inquiries less critical.
  1. Traditional Pharmacological Approaches:
    There has been a noticeable decrease in studies focused solely on traditional pharmacological treatments for cardiovascular disease, as newer therapies and combination strategies gain prominence.
  2. Basic Science and Pathophysiology:
    Research purely focused on basic science aspects of cardiovascular disease pathophysiology has waned, with a greater emphasis now placed on clinical applications and translational research.
  3. Single-Center Studies:
    The prevalence of studies conducted at single centers has diminished, with a shift towards larger, multicenter trials that offer broader generalizability and more robust data.
  4. Invasive Monitoring Techniques:
    There is less emphasis on traditional invasive monitoring techniques as non-invasive alternatives and advanced imaging modalities become more prevalent in clinical practice.
  5. General Cardiovascular Risk Scores:
    The use of generalized cardiovascular risk scores has declined in favor of more personalized and specific risk assessment models that take into account individual patient characteristics.

Similar Journals

CURRENT CARDIOLOGY REVIEWS

Advancing Cardiovascular Knowledge for Better Outcomes
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-403XFrequency: 4 issues/year

CURRENT CARDIOLOGY REVIEWS, an esteemed journal published by BENTHAM SCIENCE PUBL LTD, is a pivotal resource in the field of cardiology and cardiovascular medicine. With an ISSN of 1573-403X and E-ISSN of 1875-6557, this journal presents comprehensive reviews that contribute significantly to the advancement of scientific knowledge and clinical practices in cardiology. Operating with open access options, CURRENT CARDIOLOGY REVIEWS is dedicated to bridging the gap between research and practice, thereby encouraging interdisciplinary collaboration and knowledge sharing. The journal has been instrumental in disseminating high-impact findings, consistently maintaining a Q2 category ranking in both Cardiology and Cardiovascular Medicine, as well as within the miscellaneous categories of Medicine, highlighting its relevance and respect in the academic community. Researchers, practitioners, and students alike will find valuable insights into contemporary cardiovascular issues, practices, and innovations that promote better patient outcomes. Based in the United Arab Emirates, CURRENT CARDIOLOGY REVIEWS encourages global contributions and reflects the latest advancements up to the year 2024, solidifying its role as an essential publication for those engaged in the quest for excellence in cardiovascular health.

CURRENT PROBLEMS IN CARDIOLOGY

Advancing Insights in Cardiovascular Challenges
Publisher: MOSBY-ELSEVIERISSN: 0146-2806Frequency: 12 issues/year

CURRENT PROBLEMS IN CARDIOLOGY is a leading peer-reviewed journal published by MOSBY-ELSEVIER, dedicated to advancing the field of cardiology through comprehensive analyses of contemporary challenges faced by cardiovascular practitioners. With its ISSN 0146-2806 and E-ISSN 1535-6280, this esteemed journal has been a crucial resource for researchers, clinicians, and students alike since its inception in 1976, and continues to publish groundbreaking studies and reviews up until 2024. As a testament to its scholarly impact, CURRENT PROBLEMS IN CARDIOLOGY boasts a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine, as well as in the broader category of Medicine (miscellaneous) in the 2023 metrics, positioning it among the top journals in its field. With a Scopus ranking of #127 out of 387 in Cardiology, and a 67th percentile ranking, it remains a vital platform for disseminating high-quality research that addresses critical issues in cardiovascular health. Researchers and practitioners looking to stay at the forefront of cardiac medicine will find this journal an indispensable tool for informed decision-making and practice improvement.

Heart Lung and Circulation

Pioneering Research in Cardiovascular Medicine
Publisher: ELSEVIER SCIENCE INCISSN: 1443-9506Frequency: 12 issues/year

Heart Lung and Circulation, published by Elsevier Science Inc, is a premier peer-reviewed journal that focuses on the dynamic fields of cardiology, cardiovascular medicine, and pulmonary and respiratory medicine. With its ISSN 1443-9506 and E-ISSN 1444-2892, this journal has established itself as a significant contributor to the scientific community since its inception in 2000 and continues to publish cutting-edge research through 2024. Ranked in the Q2 category for both Cardiology and Pulmonary and Respiratory Medicine for 2023, it reflects a strong impact within its discipline. While the journal operates under a subscription model, it offers a comprehensive platform for disseminating significant developments, case studies, and reviews pertinent to practitioners, researchers, and students alike. The journal's focus on bridging the gaps in knowledge surrounding heart and lung physiology underscores its vital role in enhancing patient care and informing clinical practices.

Netherlands Heart Journal

Advancing Cardiovascular Knowledge for a Healthier Tomorrow
Publisher: BOHN STAFLEU VAN LOGHUM BVISSN: 1568-5888Frequency: 12 issues/year

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

Frontiers in Cardiovascular Medicine

Unlocking Innovations in Cardiovascular Medicine.
Publisher: FRONTIERS MEDIA SAISSN: 2297-055XFrequency: 1 issue/year

Frontiers in Cardiovascular Medicine is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing research in the field of cardiology and cardiovascular medicine. Since its inception in 2014, the journal has become a vital platform for the dissemination of high-quality research, boasting a commendable Q2 rank in the 2023 category for Cardiology and Cardiovascular Medicine. With a focus on promoting innovative studies and clinical insights, Frontiers in Cardiovascular Medicine facilitates open access to its content, allowing researchers, healthcare professionals, and students from around the globe to engage with the latest findings which are critical for the advancement of cardiovascular health. The journal's significant presence in the academic landscape, as indicated by its Scopus ranking (161/387 and 58th percentile), underscores its importance as a research outlet in this essential field. Located in Lausanne, Switzerland, the journal continues to support the global cardiovascular community by encouraging collaboration and knowledge sharing to address the challenges faced in cardiovascular medicine today.

Arquivos Brasileiros de Cardiologia

Exploring the frontiers of cardiovascular science since 1950.
Publisher: ARQUIVOS BRASILEIROS CARDIOLOGIAISSN: 0066-782XFrequency: 12 issues/year

Arquivos Brasileiros de Cardiologia is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. Established in 1950 and published by the ARQUIVOS BRASILEIROS CARDIOLOGIA, this Brazilian journal plays a crucial role in disseminating high-quality research that addresses both emerging and established topics in cardiovascular science. With an impressive history and a commitment to open access since 1997, it provides researchers, healthcare professionals, and students with free and readily available content that significantly contributes to the understanding and management of cardiovascular diseases. The journal is indexed in Scopus and holds a Q3 ranking in the category of Cardiology and Cardiovascular Medicine, demonstrating its relevance and participation within the global research community. Researchers can submit their work and access a wealth of information that spans a variety of subfields, reflecting the journal’s dedication to fostering innovation and collaboration within cardiology. With a mailing address at Avenida Marechal Câmara, 160-330 Centro, Rio de Janeiro, RJ 20,020-907, Brazil, the journal continues to serve as a vital platform for scholarly communication and knowledge exchange in the cardiovascular realm.

JOURNAL OF CARDIAC SURGERY

Innovating surgical techniques for a healthier heart.
Publisher: WILEY-HINDAWIISSN: 0886-0440Frequency: 1 issue/year

The Journal of Cardiac Surgery, published by Wiley-Hindawi, stands as a pivotal resource in the fields of cardiology, cardiovascular medicine, and surgery, addressing critical developments and innovations in surgical techniques and patient management. Established in 1986, this esteemed journal has cultivated a reputation for nurturing high-quality research, as evidenced by its 2023 Scopus rankings, placing it in the top half for both Medicine: Surgery and Medicine: Cardiology and Cardiovascular Medicine. With an impact factor indicative of its influence in the scientific community, the journal is an essential platform for researchers, medical professionals, and students eager to stay abreast of advancements in cardiac surgery. Readers can access a range of original articles, reviews, and case studies that contribute significantly to our understanding of surgical practices and outcomes. As it converges towards its 2024 milestone, the journal continues to emphasize the importance of innovation in cardiac care, underscoring its commitment to improving patient outcomes worldwide.

ACTA CARDIOLOGICA

Illuminating the path to better cardiovascular care.
Publisher: TAYLOR & FRANCIS LTDISSN: 0001-5385Frequency: 6 issues/year

ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.

International Cardiovascular Research Journal

Exploring the frontiers of cardiology and cardiovascular health.
Publisher: SHIRAZ UNIV MEDICAL SCIENCES, CARDIOVASCULAR RESEARCH CENTERISSN: 2251-9130Frequency: 4 issues/year

International Cardiovascular Research Journal, published by Shiraz University Medical Sciences, serves as a vital platform for the dissemination of cutting-edge research in the field of cardiology and cardiovascular medicine. Since its inception in 2011, this journal has continuously devoted itself to promoting the highest quality of scholarly communication, helping to bridge the gap between laboratory findings and clinical application. With an ISSN of 2251-9130 and an E-ISSN of 2251-9149, it is indexed in prominent databases, contributing to its visibility and accessibility to a global audience. Although currently classified in the Q4 quartile in the 2023 rankings, the journal is committed to enhancing its impact factor and academic stature. It aims to facilitate open access for all published articles, although specific details on access options are pending. Through its rigorous peer-review process and diverse scope—which encapsulates advancements, clinical studies, and innovative therapeutic strategies—this journal fosters academic collaboration in the realm of cardiovascular health, making it an invaluable resource for researchers, practitioners, and students alike.

Archives of Cardiovascular Diseases

Advancing cardiovascular health through groundbreaking research.
Publisher: ELSEVIER MASSON, CORP OFFISSN: 1875-2136Frequency: 12 issues/year

The Archives of Cardiovascular Diseases, published by Elsevier Masson, stands as a leading journal in the field of cardiology and cardiovascular medicine, with an impressive impact factor that underscores its relevance and influence. This esteemed journal, recognized in the Q2 category for both cardiology and miscellaneous medicine, aims to disseminate groundbreaking research, innovative methodologies, and clinical advancements that can shape the future of cardiovascular health. With its diverse array of open access options, researchers and students alike have the ability to engage with high-quality content, ensuring that cutting-edge findings are accessible globally. Since its inception in 2008, the journal has actively contributed to the advancement of knowledge in cardiovascular diseases, fostering collaboration among clinicians, researchers, and educators. Headquartered in Paris, France, Archives of Cardiovascular Diseases remains committed to enhancing our understanding of cardiovascular health and improving patient outcomes worldwide.